4//SEC Filing
Schuling Douglas A 4
Accession 0001181431-11-016271
CIK 0001138412other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 9:12 PM ET
Size
7.5 KB
Accession
0001181431-11-016271
Insider Transaction Report
Form 4
GENOPTIX INCGXDX
Schuling Douglas A
Ex VP and CFO
Transactions
- Disposition to Issuer
Common Stock
2011-03-07$25.00/sh−6,517$162,925→ 75 total - Disposition to Issuer
Employee Stock Option (right to buy)
2011-03-07$23.76/sh−2,211$52,533→ 0 totalExercise: $1.24Exp: 2016-07-16→ Common Stock (2,211 underlying)
Footnotes (3)
- [F1]Represents unvested RSUs outstanding immediately prior to the closing of the merger of GO Merger Sub, Inc. ("GO") with and into the Issuer on March 7, 2011 (the "Merger") pursuant to the Agreement and Plan of Merger, dated January 24, 2011 among the Issuer, GO and Novartis Finance Corporation (the "Merger Agreement") that were converted into an award of RSUs that is subject to the same terms and conditions as were applicable to the RSUs prior to the Merger, except that, upon the vesting of such awards the reporting person will be issued the number of shares of Novartis AG as traded on the NYSE pursuant to the formula set forth in the Merger Agreement.
- [F2]Includes 75 shares acquired under the Genoptix employee stock purchase plan on March 4, 2011.
- [F3]This option, which was fully vested, was terminated in the Merger and exchanged into the right to receive in cash the amount per share by which $25.00 exceeds the exercise price of the option, subject to any applicable tax withholdings.
Documents
Issuer
GENOPTIX INC
CIK 0001138412
Entity typeother
Related Parties
1- filerCIK 0001414837
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 9:12 PM ET
- Size
- 7.5 KB